[37th SRE][Worst] LGCHEM,LTD Faces a Series of Setbacks, Including a Credit Rating Split Amid the Petrochemical Downturn
[37th SRE]
71 out of 197 Respondents Say “Credit Rating Is Inappropriate”
“It Will Be Difficult to Restore Financial Stability During the Suspension Period”
[Edaily Marketin, Reporter KIM YEON-SEO ] LGCHEM,LTD, which ranked 9th in the “Worst Ratings” category of the 36th Credit Rating Experts Survey (SRE), has risen to 2nd place this year. Concerns about LGCHEM,LTD’s creditworthiness are growing amid a prolonged slump in the petrochemical industry, compounded by credit rating splits among credit rating agencies. Market sentiment suggests that a credit rating downgrade is necessary.
◇LGCHEM,LTD: 24th in the 35th Survey → 9th in the 36th Survey → 2nd in the 37th Survey
In the 37th SRE, 71 out of 197 bond market experts (36.04%) responded that LGCHEM,LTD’s credit rating was inappropriate. LGCHEM,LTD, which ranked 24th in the 35th SRE and 9th in the 36th SRE, climbed 15 spots last year and 7 spots this year to reach 2nd place. Of the 71 respondents who selected LGCHEM,LTD, 62 believed the rating should be downgraded, while 9 stated that an upgrade should be considered. By job function, 22 credit analysts (CA) and 40 non-CA respondents believed the rating should be downgraded, while 2 CAs and 7 non-CA respondents believed it should be upgraded.
LGCHEM,LTD’s rise in the “worst-rated” rankings is interpreted as reflecting market concerns over the deteriorating conditions in the petrochemical industry. Analysts note that while credit risk concerns were previously concentrated in the construction sector, they have recently shifted to the petrochemical sector, raising growing doubts about the appropriateness of credit ratings for related companies.
An SRE advisory committee member stated, “Although LGCHEM,LTD has firmly maintained an ‘AA+’ credit rating for a long time, it has recently found itself among the top-ranked companies in the worst-rated category,” adding, “While concerns about the construction sector were significant during the 33rd SRE, starting with the 35th SRE, the petrochemical sector has emerged as the sector with the greatest concerns regarding a deteriorating business environment. “A number of petrochemical companies also made the list in this round of worst-rated companies,” the advisor added.
Currently, LGCHEM,LTD’s credit rating is subject to a split among the three major domestic credit rating agencies. On June 19, Korea Ratings Corporation downgraded LGCHEM,LTD’s credit rating by one notch from “AA+” to “AA” and changed the outlook from “Negative” to “Stable.” In contrast, Korea Credit Rating and NICEHoldings have maintained the “AA+” rating with a “Negative” outlook.
The prevailing view in the market is that a downgrade of LGCHEM,LTD’s credit rating is necessary. However, analysts note that as government-led restructuring of the petrochemical sector is underway, credit rating agencies are carefully assessing the timing of any rating adjustments. This is because they need to confirm the effects of the restructuring on the company’s financial structure.
If the rating split among credit rating agencies persists for an extended period, market uncertainty could increase. This is because investors’ conservative assessment of credit risk could lead to higher interest rates on corporate bond issuances and increased financing costs.
In this regard, an SRE advisory committee member noted, “Given the poor business conditions in the petrochemical sector, many related companies are included among the top-ranked firms in this ‘worst-rated’ list,” adding, “Although these companies already have negative rating outlooks, the government’s restructuring efforts combined with temporary windfalls resulting from the war have created a situation where credit rating agencies are finding it difficult to determine the appropriate timing for a downgrade.”
◇370 billion won in corporate bonds maturing in 2027… Will the company proceed with a refinancing issue?
LGCHEM,LTD is facing the maturity of corporate bonds totaling 370 billion won in February and March of next year. With a credit rating split having occurred, attention is focused on whether the company will proceed with a refinancing issuance.
According to BondWeb, LGCHEM,LTD has corporate bonds totaling 370 billion won maturing next year: 50 billion won on February 19 and 320 billion won on March 5. In 2028, maturities totaling 815 billion won are also scheduled: 380 billion won on January 24, 235 billion won on January 25, and 200 billion won on February 19.
Previously, LGCHEM,LTD achieved a successful offering last January when it received 1.675 trillion won in orders during the bookbuilding process for a 300 billion won public corporate bond issue. At that time, the tranches (maturities) consisted of 3-, 5-, and 7-year bonds; in particular, the 150 billion won 3-year tranche attracted 1.265 trillion won in funds.
However, there is speculation that it may not be easy to secure the same level of investor demand in future corporate bond issuances. This is due to delays in the recovery of the petrochemical industry and the occurrence of a credit rating split. In particular, analysts suggest that the possibility of further rating downgrades could weigh on institutional investors’ investment decisions.
LGCHEM,LTD is also utilizing funding methods other than corporate bonds. On the 28th, LGCHEM,LTD announced that it plans to enter into a Price Return Swap (PRS) contract worth approximately 2.5 trillion won, using shares of its subsidiary, LG Energy Solution, as the underlying asset. The underlying shares consist of 6,535,939 common shares of LG Energy Solution, with a reference price of 382,500 won per share. The contract term is two years, and the sale of the shares is scheduled to take place from November 27 to December 24.
An investment banking (IB) industry official stated, “In a situation where a credit rating downgrade is possible, institutional investors are reluctant to invest,” adding, “Investing in bonds whose ratings have already been downgraded is different from investing in bonds that may be downgraded after the investment is made. From an investor’s perspective, they cannot help but be concerned about the potential for losses resulting from a future rating downgrade.” The source continued, “In a situation like this, where uncertainty regarding creditworthiness has increased, issuers are turning to other means of raising capital, such as PRS, instead of issuing corporate bonds.”
◇“LGCHEM,LTD Unlikely to Restore Financial Stability During Suspension Period”
Credit rating agencies cite LGCHEM,LTD’s poor performance in the petrochemical sector and increased debt resulting from expanded investments as the main factors behind its credit downgrade. The analysis indicates that financial stability has deteriorated as profit-generating capacity weakened due to the downturn in the petrochemical industry, compounded by the investment burden associated with expanding production facilities for secondary batteries and cathode materials.
According to Korea Ratings Corporation, LGCHEM,LTD’s operating profit in the petrochemical sector plummeted from 4.0815 trillion won in 2021 to 1.0745 trillion won in 2022. The company has been in the red since 2023, with its operating loss expanding to 356.4 billion won last year. This is the result of a combination of factors, including a supply glut originating in China, uncertainty surrounding global trade policies, and shrinking demand due to escalating geopolitical risks.
The debt burden also grew rapidly. Following large-scale investments since 2022 to expand production facilities for lithium-ion batteries and cathode materials, net debt increased approximately threefold, from 7.4522 trillion won at the end of 2022 to 22.9092 trillion won at the end of last year. During the same period, the debt-to-equity ratio rose from 81.4% to 114.5%, and the debt dependency ratio also increased from 23.5% to 33.5%.
Cash generation capacity has also weakened. The net debt-to-adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) ratio rose from 1.2x at the end of 2022 to 3.6x at the end of last year, while the adjusted EBITDA-to-financial expenses ratio fell from 19.8x to 5.3x over the same period.
Although the petrochemical division’s performance has temporarily improved this year, its sustainability remains uncertain. LGCHEM,LTD posted an operating profit of 164.8 billion won in the first quarter of this year due to rising petrochemical product prices resulting from the U.S.-Iran conflict and the blockade of the Strait of Hormuz. This was influenced by a positive lag effect arising from the time difference between raw material procurement and product sales.
However, Han Ki-pyeong predicted that profitability could decline again once the conflict ends, due to narrowing product spreads and inventory losses. It also anticipated that the burden of oversupply would be difficult to resolve in the short term, as China has already made significant progress in expanding its petrochemical production capacity.
Han Min-soo, a senior researcher in Corporate Division 1 at Han Ki-pyeong, stated, “We expect the company to cover a certain level of its funding needs with operating cash flow and to manage its financial burden through alternative funding sources,” adding “However, given that there is limited room for improvement in operating cash flow generation in the near term, we believe it will take time to restore financial stability to pre-2023 levels through the generation of excess cash flow,” he added.
[This article is excerpted from the 37th edition of the SRE (Survey of Credit Ratings by Edaily) booklet produced by Edaily.]
LGCHEM,LTD, which ranked 9th in the “Worst Ratings” category of the 36th Credit Rating Experts Survey (SRE), has risen to 2nd place this year. Concerns about LGCHEM,LTD’s creditworthiness are growing …
E-MART Co., Ltd.(139480)and Nobland International Inc. are accelerating their push into the low-price cosmetics market. Nobland International Inc. has expanded its product lineup beyond its traditiona…
DuChemBio Co.,LTD.(176750)continued its revenue growth in the third quarter, driven by increased sales of radiopharmaceuticals for the diagnosis of Alzheimer’s disease. With the domestic launch of Eli…